Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guangtong Deng

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Bioscience Reports|October 26, 2019
Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinomaLiang Xiao, Furong Zeng, Guangtong Deng
Molecular Biomedicine|June 15, 2023
Disulfidptosis: a new form of regulated cell death for cancer treatmentYu Meng, Xiang Chen, Guangtong Deng
Signal Transduction and Targeted Therapy|February 22, 2023
Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapySongtao Du, Furong Zeng, Guangtong Deng
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2020
Convalescent plasma for patients with COVID-19Furong Zeng, Xiang Chen, Guangtong Deng
Molecular Biomedicine|November 29, 2022
The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approachFurong Zeng, Xiang Chen, Guangtong Deng
International Journal of Medical Education|April 26, 2016
WeChat: a new clinical teaching tool for problem-based learningFurong Zeng, Guangtong Deng, Zhao Wang, et al.
Cell Death and Differentiation|March 26, 2026
Extracellular GPX4 functions as an immunosuppressive DAMP in ferroptosisYu Meng, Daishi Li, Xiang Chen, et al.
Frontiers in Medicine|May 17, 2024
Editorial: The impact of the COVID-19 pandemic on dermatology patients: diagnosis, treatment, and prognosisHuining Huang, Ziyu Guo, Danyao Chen, et al.
Journal of Medical Virology|July 5, 2023
Evaluate clinical effectiveness of Azvudine with data rather than speculationDaishi Li, Yihuang Liu, Minxue Shen, et al.
Heliyon|November 13, 2023
Clinical characteristics, outcomes, and risk factors of SARS-CoV-2 breakthrough infections among 572 fully vaccinated (BBIBP-CorV) hospitalized patientsYihuang Liu, Peilin Liu, Yuming Sun, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Bioscience Reports|October 26, 2019
Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinomaLiang Xiao, Furong Zeng, Guangtong Deng
Molecular Biomedicine|June 15, 2023
Disulfidptosis: a new form of regulated cell death for cancer treatmentYu Meng, Xiang Chen, Guangtong Deng
Signal Transduction and Targeted Therapy|February 22, 2023
Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapySongtao Du, Furong Zeng, Guangtong Deng
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2020
Convalescent plasma for patients with COVID-19Furong Zeng, Xiang Chen, Guangtong Deng
Molecular Biomedicine|November 29, 2022
The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approachFurong Zeng, Xiang Chen, Guangtong Deng
International Journal of Medical Education|April 26, 2016
WeChat: a new clinical teaching tool for problem-based learningFurong Zeng, Guangtong Deng, Zhao Wang, et al.
Cell Death and Differentiation|March 26, 2026
Extracellular GPX4 functions as an immunosuppressive DAMP in ferroptosisYu Meng, Daishi Li, Xiang Chen, et al.
Frontiers in Medicine|May 17, 2024
Editorial: The impact of the COVID-19 pandemic on dermatology patients: diagnosis, treatment, and prognosisHuining Huang, Ziyu Guo, Danyao Chen, et al.
Journal of Medical Virology|July 5, 2023
Evaluate clinical effectiveness of Azvudine with data rather than speculationDaishi Li, Yihuang Liu, Minxue Shen, et al.
Heliyon|November 13, 2023
Clinical characteristics, outcomes, and risk factors of SARS-CoV-2 breakthrough infections among 572 fully vaccinated (BBIBP-CorV) hospitalized patientsYihuang Liu, Peilin Liu, Yuming Sun, et al.
Pageof 10